Abstract

Hypoxia is characteristic of living at high altitude. Animal and human studies have shown that chronic hypoxia is associated with changes in the brain. Neurological symptoms are common in high altitude populations. Headaches, paresthesias, physical and mental fatigue have been described at high altitude (Arregui et al 1991; Appenzeller et al. 2002; Winslow and Monge 1987). Furthermore, these symptoms are frequent in Monge’s disease or chronic mountain sickness (CMS), a disease that develops after many years of residing at high altitude. It is characterized by excessive erythrocytosis, hypoxemia, headache, dizziness, tinnitus, breathlessness, sleep disturbances, physical and mental fatigue and dilation of the veins (Winslow and Monge 1987). Notable among CMS symptoms is migraine headache, which is particularly frequent at high altitude, being approximately 4 times more frequent than sea level populations 1 (Fig. 1). The recent retrospective study by Brenner et al. (2011) involving most U.S. counties, which spanned 20 years, reported a dramatic increase of suicide in high altitude populations. This finding was independent of demographic factors usually associated with suicide such as age, race, gender, or income. The higher suicide rate at high altitude is not explained by increased overall mortality since there is a negative correlation between altitude and overall mortality. Previous findings from our group may shed some light on this finding (Arregui 1995; Arregui et al 1995). Using epidemiological surveys we described an increased prevalence of depression in men living at high altitude compared with those living at sea level (see Fig 1A). Moreover, migraines and CMS occur more frequently at high altitude. In addition, depression is associated with the presence of migraines and CMS at high altitude (Arregui et al 1995) (see Fig 1B). Depression is responsible for the majority of suicide cases worldwide (Henriksson et al. 1993). Therefore, increased depression prevalence at high altitude populations may explain the association of increased suicide rate at high altitude (Brenner et al. 2011). Currently, the contribution of migraine in the association between suicide and high altitude is not entirely clear. However, migraine is also a risk factor for psychiatric disorders, including depression (Pompili et al. 2010). Both, depression and migraine are associated with serotonin related abnormalities, and both are part of the chronic mountain sickness symptomatology. However, further reFIG. 1. Odds ratios for high altitude and neuropsychiatric symptoms. (A). High altitude is associated with the presence of migraine and depression. The rates of migraine and depression were compared in high altitude and sea level natives. (B). At high altitude (4300 m) depression is associated with the occurrence of migraine and chronic mountain sickness (CMS). Odds ratios and 95% confidence intervals were calculated from Arregui et al. 1991*, Arregui 1995, and Arregui et al 1995 using 2 · 2 contigency tables through StatCalc utility software (Epi Info 2010, CDC Atlanta, Georgia).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call